TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr | ₹5,696 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹6,796 Cr |
Mar2023 | ₹6,077 Cr |
Mar2022 | ₹5,524 Cr |
Mar2021 | ₹5,769 Cr |
Mar2020 | ₹5,696 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹6,796 Cr | 11.84 | |
Mar2023 | ₹6,077 Cr | 10.00 | |
Mar2022 | ₹5,524 Cr | -4.24 | |
Mar2021 | ₹5,769 Cr | 1.28 | |
Mar2020 | ₹5,696 Cr | - |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,458.9 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.8% |
6.8% |
25.6% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses